1. Product
Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3. Key Market
Segmentations
2. Research
Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive
Summary
3.1. Overview of the
Market
3.2. Overview of Key
Market Segmentations
3.3. Overview of Key
Market Players
3.4. Overview of Key
Regions/Countries
3.5. Overview of Market Drivers,
Challenges, Trends
4. Voice
of Customer
5.
Global Plasma Fractionation
Market Outlook
5.1. Market
Size & Forecast
5.1.1. By
Value
5.2. Market
Share & Forecast
5.2.1.
By Product (Albumin, Immunoglobulins,
Coagulation Factors, Protease Inhibitors, Others)
5.2.2.
By Method (Centrifugation, Depth Filtration,
Chromatography, Others)
5.2.3.
By Application (Neurology, Hematology,
Oncology, Immunology, Others)
5.2.4.
By End User (Hospitals & Clinics,
Academic & Research Institutes, Others)
5.2.5.
By Region
5.2.6. By
Company (2022)
5.3. Market
Map
5.3.1. By
Product
5.3.2. By Method
5.3.3. By
Application
5.3.4. By End
User
5.3.5. By
Region
6.
North America Plasma Fractionation
Market Outlook
6.1. Market
Size & Forecast
6.1.1. By
Value
6.2. Market
Share & Forecast
6.2.1.
By Product
6.2.2.
By Method
6.2.3.
By Application
6.2.4.
By End User
6.2.5. By
Country
6.3. North
America: Country Analysis
6.3.1. United
States Plasma Fractionation Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Product
6.3.1.2.2.
By Method
6.3.1.2.3.
By Application
6.3.1.2.4.
By End User
6.3.2. Canada
Plasma Fractionation Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Product
6.3.2.2.2.
By Method
6.3.2.2.3.
By Application
6.3.2.2.4.
By End User
6.3.3. Mexico
Plasma Fractionation Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Product
6.3.3.2.2.
By Method
6.3.3.2.3.
By Application
6.3.3.2.4.
By End User
7.
Europe Plasma Fractionation
Market Outlook
7.1. Market
Size & Forecast
7.1.1. By
Value
7.2. Market
Share & Forecast
7.2.1.
By Product
7.2.2.
By Method
7.2.3.
By Application
7.2.4.
By End User
7.2.5.
By Country
7.3. Europe:
Country Analysis
7.3.1. France
Plasma Fractionation Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Product
7.3.1.2.2.
By Method
7.3.1.2.3.
By Application
7.3.1.2.4.
By End User
7.3.2. Germany
Plasma Fractionation Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Product
7.3.2.2.2.
By Method
7.3.2.2.3.
By Application
7.3.2.2.4.
By End User
7.3.3. United
Kingdom Plasma Fractionation Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Product
7.3.3.2.2.
By Method
7.3.3.2.3.
By Application
7.3.3.2.4.
By End User
7.3.4. Italy
Plasma Fractionation Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Product
7.3.4.2.2.
By Method
7.3.4.2.3.
By Application
7.3.4.2.4.
By End User
7.3.5. Spain
Plasma Fractionation Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Product
7.3.5.2.2.
By Method
7.3.5.2.3.
By Application
7.3.5.2.4.
By End User
8.
Asia-Pacific Plasma Fractionation
Market Outlook
8.1. Market
Size & Forecast
8.1.1. By
Value
8.2. Market
Share & Forecast
8.2.1.
By Product
8.2.2.
By Method
8.2.3.
By Application
8.2.4.
By End User
8.2.5. By
Country
8.3. Asia-Pacific:
Country Analysis
8.3.1. China
Plasma Fractionation Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Product
8.3.1.2.2.
By Method
8.3.1.2.3.
By Application
8.3.1.2.4.
By End User
8.3.2. India
Plasma Fractionation Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Product
8.3.2.2.2.
By Method
8.3.2.2.3.
By Application
8.3.2.2.4.
By End User
8.3.3. Japan
Plasma Fractionation Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Product
8.3.3.2.2.
By Method
8.3.3.2.3.
By Application
8.3.3.2.4.
By End User
8.3.4. South
Korea Plasma Fractionation Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Product
8.3.4.2.2.
By Method
8.3.4.2.3.
By Application
8.3.4.2.4.
By End User
8.3.5. Australia
Plasma Fractionation Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Product
8.3.5.2.2.
By Method
8.3.5.2.3.
By Application
8.3.5.2.4.
By End User
9.
South America Plasma Fractionation
Market Outlook
9.1. Market
Size & Forecast
9.1.1. By
Value
9.2. Market
Share & Forecast
9.2.1.
By Product
9.2.2.
By Method
9.2.3.
By Application
9.2.4.
By End User
9.2.5. By Country
9.3. South
America: Country Analysis
9.3.1. Brazil
Plasma Fractionation Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Product
9.3.1.2.2.
By Method
9.3.1.2.3.
By Application
9.3.1.2.4.
By End User
9.3.2. Argentina
Plasma Fractionation Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Product
9.3.2.2.2.
By Method
9.3.2.2.3.
By Application
9.3.2.2.4.
By End User
9.3.3. Colombia
Plasma Fractionation Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Product
9.3.3.2.2.
By Method
9.3.3.2.3.
By Application
9.3.3.2.4.
By End User
10. Middle
East and Africa Plasma Fractionation Market Outlook
10.1.
Market Size & Forecast
10.1.1. By
Value
10.2.
Market Share & Forecast
10.2.1.
By Product
10.2.2.
By Method
10.2.3.
By Application
10.2.4.
By End User
10.2.5. By
Country
10.3.
MEA: Country Analysis
10.3.1. South
Africa Plasma Fractionation Market Outlook
10.3.1.1. Market
Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market
Share & Forecast
10.3.1.2.1.
By Product
10.3.1.2.2.
By Method
10.3.1.2.3.
By Application
10.3.1.2.4.
By End User
10.3.2. Saudi
Arabia Plasma Fractionation Market Outlook
10.3.2.1. Market
Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market
Share & Forecast
10.3.2.2.1.
By Product
10.3.2.2.2.
By Method
10.3.2.2.3.
By Application
10.3.2.2.4.
By End User
10.3.3. UAE Plasma
Fractionation Market Outlook
10.3.3.1. Market
Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market
Share & Forecast
10.3.3.2.1.
By Product
10.3.3.2.2.
By Method
10.3.3.2.3.
By Application
10.3.3.2.4.
By End User
10.3.4. Turkey
Plasma Fractionation Market Outlook
10.3.4.1. Market
Size & Forecast
10.3.4.1.1.
By Value
10.3.4.2. Market
Share & Forecast
10.3.4.2.1.
By Product
10.3.4.2.2.
By Method
10.3.4.2.3.
By Application
10.3.4.2.4.
By End User
10.3.5. Egypt
Plasma Fractionation Market Outlook
10.3.5.1. Market
Size & Forecast
10.3.5.1.1.
By Value
10.3.5.2. Market
Share & Forecast
10.3.5.2.1.
By Product
10.3.5.2.2.
By Method
10.3.5.2.3.
By Application
10.3.5.2.4.
By End User
11. Market
Dynamics
11.1.
Drivers
11.2.
Challenges
12. Market
Trends & Developments
12.1.
Recent Developments
12.2.
Mergers & Acquisitions
12.3.
Product Launches
13. Competitive
Landscape
13.1.
Business Overview
13.2.
Product Offerings
13.3.
Recent Developments
13.4.
Financials (As Reported)
13.5.
Key Personnel
13.6.
SWOT Analysis
13.6.1. Grifols
S.A.
13.6.2. Octapharma
AG
13.6.3. Intas
Pharmaceuticals Ltd
13.6.4. LFB
S.A.
13.6.5. Takeda
Pharmaceutical Company Limited
13.6.6. CSL
Limited
13.6.7. Biotest
AG
13.6.8. Kedrion
S.p.A
13.6.9. Bio
Products Laboratory Ltd.’
13.6.10.
Bharat Serums and Vaccines Limited
Strategic
Recommendations